应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06185 康希诺生物
交易中 12-19 14:17:46
30.350
-0.650
-2.10%
最高
30.650
最低
29.650
成交量
48.10万
今开
30.600
昨收
31.000
日振幅
3.23%
总市值
75.10亿
流通市值
40.37亿
总股本
2.47亿
成交额
1,447万
换手率
0.36%
流通股本
1.33亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
智通AH统计|12月18日
智通财经 · 12-18 16:15
智通AH统计|12月18日
《股市简讯》中国康希诺A/H股齐涨,婴幼儿百白破疫苗上市申请获药监局受理
路透中文 · 12-17 10:13
《股市简讯》中国康希诺A/H股齐涨,婴幼儿百白破疫苗上市申请获药监局受理
康希诺生物现涨超3% 婴幼儿用DTcP的新药上市申请获受理
新浪港股 · 12-17 09:48
康希诺生物现涨超3% 婴幼儿用DTcP的新药上市申请获受理
港股异动 | 康希诺生物(06185)涨超4% 婴幼儿用DTcP的新药上市申请获受理
智通财经 · 12-17 09:38
港股异动 | 康希诺生物(06185)涨超4% 婴幼儿用DTcP的新药上市申请获受理
金十数据整理:每日港股市场要闻速递(12月17日 周二)
美港电讯 · 12-17 09:02
金十数据整理:每日港股市场要闻速递(12月17日 周二)
【湾区早参】香港政府拟明年首季提选举安排修订草案;深圳首个离境退税陆路口岸退税点启用
金吾财讯 · 12-17 08:34
【湾区早参】香港政府拟明年首季提选举安排修订草案;深圳首个离境退税陆路口岸退税点启用
康希诺生物(06185.HK)婴幼儿用DTcP新药上市申请获受理
阿斯达克财经 · 12-16 17:59
康希诺生物(06185.HK)婴幼儿用DTcP新药上市申请获受理
智通AH统计|12月16日
智通财经 · 12-16 16:15
智通AH统计|12月16日
康希诺生物(06185)委任董小曼为上海千希智的新普通合伙人
智通财经 · 12-13
康希诺生物(06185)委任董小曼为上海千希智的新普通合伙人
智通AH统计|12月13日
智通财经 · 12-13
智通AH统计|12月13日
康希诺:公司正在推进多款创新疫苗的研发工作,按照CDE的指导原则对相关事项提交申请,并积极沟通汇报
证星董秘互动 · 12-12
康希诺:公司正在推进多款创新疫苗的研发工作,按照CDE的指导原则对相关事项提交申请,并积极沟通汇报
康希诺生物(06185)下跌5.11%,报31.6元/股
金融界 · 12-12
康希诺生物(06185)下跌5.11%,报31.6元/股
康希诺生物盘中异动 早盘急速下跌5.11%
市场透视 · 12-12
康希诺生物盘中异动 早盘急速下跌5.11%
南向资金12月11日净买入康希诺生物8.46万股 连续5日增持
市场透视 · 12-12
南向资金12月11日净买入康希诺生物8.46万股 连续5日增持
智通AH统计|12月11日
智通财经 · 12-11
智通AH统计|12月11日
康希诺生物(06185)上涨5.14%,报34.75元/股
金融界 · 12-11
康希诺生物(06185)上涨5.14%,报34.75元/股
康希诺生物盘中异动 急速拉升5.14%
市场透视 · 12-11
康希诺生物盘中异动 急速拉升5.14%
智通AH统计|12月9日
智通财经 · 12-09
智通AH统计|12月9日
异动解读 | 康希诺生物(06185)盘中大涨5.02%,业务发展获市场看好
异动解读 · 12-06
异动解读 | 康希诺生物(06185)盘中大涨5.02%,业务发展获市场看好
康希诺生物盘中异动 早盘急速上涨5.17%
市场透视 · 12-06
康希诺生物盘中异动 早盘急速上涨5.17%
加载更多
公司概况
公司名称:
康希诺生物
所属市场:
SEHK
上市日期:
--
主营业务:
康希诺生物股份公司是一家处于临床阶段的中国疫苗公司。该公司的产品包括埃博拉病毒疫苗Ad5-EBOV、脑膜炎球菌疫苗MCV2和MCV4、肺炎球菌疫苗PBPV和重组新型冠状病毒疫苗等。其产品主要应用于脑膜炎、百白破和肺炎领域。
发行价格:
--
{"stockData":{"symbol":"06185","market":"HK","secType":"STK","nameCN":"康希诺生物","latestPrice":30.35,"timestamp":1734589029827,"preClose":31,"halted":0,"volume":481000,"delay":0,"floatShares":133000000,"shares":247449899,"eps":-6.44705,"marketStatus":"交易中","marketStatusCode":2,"change":-0.65,"latestTime":"12-19 14:17:46","open":30.6,"high":30.65,"low":29.65,"amount":14467750,"amplitude":0.032258,"askPrice":30.4,"askSize":2000,"bidPrice":30.2,"bidSize":4800,"shortable":3,"etf":0,"ttmEps":-3.1287609340445712,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1734595800000},"adr":0,"listingDate":1553702400000,"adjPreClose":31,"dividendRate":0.029756,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":0.91954,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":63.45,"timestamp":1734589030000,"preClose":63.29,"halted":0,"volume":1130110,"delay":0,"premium":"-55.41"}},"requestUrl":"/m/hq/s/06185","defaultTab":"news","newsList":[{"id":"2492979637","title":"智通AH统计|12月18日","url":"https://stock-news.laohu8.com/highlight/detail?id=2492979637","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492979637?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:15","pubTimestamp":1734509705,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,截止12月18日收盘,东北电气、浙江世宝、弘业期货分列AH溢价率前三位,溢价率分别为831.03%、386.67%、352.31%;美的集团、药明康德、招商银行分列AH溢价率末三位,溢价率分别为16.56%、20.65%、20.79%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226475.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01349","002594","01919","01108","03678","01812","02727","159982","00548","81211","82318","02880","01330","06185","00956","02465","02238","LU0254981946.USD","00187","00300","399300","02318","01033","01211","06655","BYDDY","00107","03145","03968","00553","HYDD.SI","688981","02218","601318","00588","00042","06806","02359","PNGAY","02338","01057","03908","03606","02899","06690","01456","03143"],"gpt_icon":1},{"id":"2492677324","title":"《股市简讯》中国康希诺A/H股齐涨,婴幼儿百白破疫苗上市申请获药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2492677324","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492677324?lang=zh_cn&edition=full","pubTime":"2024-12-17 10:13","pubTimestamp":1734401629,"startTime":"0","endTime":"0","summary":"《股市简讯》中国康希诺A/H股齐涨,婴幼儿百白破疫苗上市申请获药监局受理* 中国疫苗生产商--康希诺H股6185.HK周二早盘涨幅扩大至4%,其A股688185.SS亦一度升2.7%。* 该公司此前公告称,婴幼儿用吸附无细胞百(组分)白破联合疫苗的新药上市申请已于近日获得中国国家药监局出具的受理通知书。目前暂无国产组分百白破疫苗获批在中国上市,公司的婴幼儿用DTcP在中国的定位即为进口疫苗的可行替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL4T3NI04H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1161","BK1515","BK1574","688185","06185","BK0239"],"gpt_icon":0},{"id":"2492672898","title":"康希诺生物现涨超3% 婴幼儿用DTcP的新药上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2492672898","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492672898?lang=zh_cn&edition=full","pubTime":"2024-12-17 09:48","pubTimestamp":1734400080,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 康希诺生物(06185)早盘上涨3.05%,现报32.10港元,成交额785.49万港元。\n 康希诺生物公布,该公司研发的婴幼儿用吸附无细胞百(组分)白破联合疫苗(DTcP)(2岁以下)(婴幼儿用DTcP)的新药上市申请已于近日获得中国国家药品监督管理局(国家药监局)出具的受理通知书。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-17/doc-incztptr2127576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","06185","BK1191","BK1574","BK1161"],"gpt_icon":0},{"id":"2492324674","title":"港股异动 | 康希诺生物(06185)涨超4% 婴幼儿用DTcP的新药上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2492324674","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492324674?lang=zh_cn&edition=full","pubTime":"2024-12-17 09:38","pubTimestamp":1734399489,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,康希诺生物(06185)涨超4%,截至发稿,涨4.01%,报32.4港元,成交额494.47万港元。消息面上,康希诺生物公布,该公司研发的婴幼儿用吸附无细胞百(组分)白破联合疫苗(DTcP)(2岁以下)(婴幼儿用DTcP)的新药上市申请已于近日获得中国国家药品监督管理局(国家药监局)出具的受理通知书。公告称,目前国内在售的共纯化百白破疫苗的制造过程使用百日咳抗原共纯化的工艺,公司的婴幼儿用DTcP为组分百白破疫苗,每种百日咳抗原可以单独纯化,以确定的比例配制,从而可以确保产品质量批间的一致性,使产品的质量更加稳定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225758.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 康希诺生物(06185)涨超4% 婴幼儿用DTcP的新药上市申请获受理","news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","06185","BK1515","BK1191","BK1161"],"gpt_icon":0},{"id":"2492676432","title":"金十数据整理:每日港股市场要闻速递(12月17日 周二)","url":"https://stock-news.laohu8.com/highlight/detail?id=2492676432","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492676432?lang=zh_cn&edition=full","pubTime":"2024-12-17 09:02","pubTimestamp":1734397378,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["09900","BK1542","BK1554","BK1571","BK1148","01833","BK1142","BK1191","BK0224","BK1181","BK1555","01055","BK4099","06055","BK4588","00512","HSCEI","BK1229","00111","BK4555","HSTECH","02777","BK1123","BK4585","BK1219","YANG","BK1147","BK1247","TM","688339","03160","06185","BK1580","BK1594","BK1561","00670","BK1515","BK1171","BK1258","02402","01250","07226","BK1161","159945","BK1154","02869","BK1574","BK1514","BK1240"],"gpt_icon":0},{"id":"2492730476","title":"【湾区早参】香港政府拟明年首季提选举安排修订草案;深圳首个离境退税陆路口岸退税点启用","url":"https://stock-news.laohu8.com/highlight/detail?id=2492730476","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492730476?lang=zh_cn&edition=full","pubTime":"2024-12-17 08:34","pubTimestamp":1734395646,"startTime":"0","endTime":"0","summary":"自12月16日起,深圳文锦渡口岸正式实施境外旅客购物离境退税政策,境外旅客在该口岸离境时,其在退税商店购买的退税物品,经海关验核确认后,由相关部门联合评定的退税代理机构对其退还增值税。","market":"nz","thumbnail":"https://static.szfiu.com/news/20200915/NzYyNDljMmIwNjZjMTQ3MTljY2ZkYmY1MDAwNDcwMjMxMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NzYyNDljMmIwNjZjMTQ3MTljY2ZkYmY1MDAwNDcwMjMxMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949737","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01055","BK1515","02196","09900","BK1561","02777","BK1574","BK1240","BK1555","BK1191","BK1580","BK1161","BK1512","00670","BK1593","BK1181","BK1123","BK1114","02696","06185","06055","BK1148","06110","BK1514"],"gpt_icon":0},{"id":"2491166583","title":"康希诺生物(06185.HK)婴幼儿用DTcP新药上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2491166583","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491166583?lang=zh_cn&edition=full","pubTime":"2024-12-16 17:59","pubTimestamp":1734343140,"startTime":"0","endTime":"0","summary":"康希诺生物(06185.HK) 宣布,公司研发的婴幼儿用吸附无细胞百(组分)白破联合疫苗(DTcP)(2岁以下),其新药上市申请已于近日获得国家药监局受理。(gc/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-16 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230120154911522_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230120154911522_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1404421/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1515","BK1191","06185","BK1161"],"gpt_icon":0},{"id":"2491659880","title":"智通AH统计|12月16日","url":"https://stock-news.laohu8.com/highlight/detail?id=2491659880","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491659880?lang=zh_cn&edition=full","pubTime":"2024-12-16 16:15","pubTimestamp":1734336905,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,截止12月16日收盘,东北电气、浙江世宝、弘业期货分列AH溢价率前三位,溢价率分别为847.37%、390.07%、370.61%;美的集团、招商银行、药明康德分列AH溢价率末三位,溢价率分别为19.97%、20.69%、21.42%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01211","01055","02899","03968","81211","GWLLY","02866","02359","00187","00588","00553","03143","00548","PNGAY","399300","01339","01812","688981","01635","HYDD.SI","01033","601318","00300","02333","06865","03678","01349","02238","02338","BYDDY","03606","06690","159982","02727","01528","03145","00956","06185","82318","01919","601633","02218","01330","06655","00916","00042","01057"],"gpt_icon":1},{"id":"2491706320","title":"康希诺生物(06185)委任董小曼为上海千希智的新普通合伙人","url":"https://stock-news.laohu8.com/highlight/detail?id=2491706320","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491706320?lang=zh_cn&edition=full","pubTime":"2024-12-13 21:44","pubTimestamp":1734097493,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康希诺生物(06185)发布公告,于2024年12月13日,朱博士通知董事会,鉴于管理员工持股平台需要充足的时间,为专注于公司的核心业务发展,员工持股平台的全体合伙人一致决议分别委任李炜为上海千希益和上海千希睿的新普通合伙人,委任董小曼为上海千希智的新普通合伙人,二者均为独立第三方。因此,朱博士不再是员工持股平台的普通合伙人,不再有权行使员工持股平台所持股份的投票权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","BK1515","BK1191","06185"],"gpt_icon":0},{"id":"2491348766","title":"智通AH统计|12月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2491348766","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491348766?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:15","pubTimestamp":1734077705,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,截止12月13日收盘,东北电气、浙江世宝、弘业期货分列AH溢价率前三位,溢价率分别为847.37%、385.81%、366.67%;美的集团、招商银行、药明康德分列AH溢价率末三位,溢价率分别为18.42%、18.51%、20.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224511.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601318","BYDDY","688981","82318","01211","01055","BK1507","02238","01033","02318","399300","00553","00670","00916","01057","06690","06185","01812","01330","01349","02338","02899","02218","06655","03143","00042","01919","03968","02359","00588","01339","159982","002594","HYDD.SI","00187","01528","02009","02727","00300","03145","02866","03606","03678","00548","81211","01635","PNGAY"],"gpt_icon":1},{"id":"2490806136","title":"康希诺:公司正在推进多款创新疫苗的研发工作,按照CDE的指导原则对相关事项提交申请,并积极沟通汇报","url":"https://stock-news.laohu8.com/highlight/detail?id=2490806136","media":"证星董秘互动","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490806136?lang=zh_cn&edition=full","pubTime":"2024-12-12 19:00","pubTimestamp":1734001250,"startTime":"0","endTime":"0","summary":"证券之星消息,康希诺(688185)12月12日在投资者关系平台上答复投资者关心的问题。投资者:您好,截止12月10日,贵司A股股东人数有多少?康希诺董秘:尊敬的投资人您好,根据中国证券登记结算有限责任公司下发的公司2024年12月10日A股股东名册,持有人数为19158人。谢谢!投资者:您好,CDE官网显示,贵司11月15日申请的II类会议已反馈,请问,是什么沟通交流?康希诺董秘:尊敬的投资人您好,公司正在推进多款创新疫苗的研发工作,按照CDE的指导原则对相关事项提交申请,并积极沟通汇报。如有阶段性进展,会及时分享。谢谢!以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212190220ab723aa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212190220ab723aa8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1161","BK1515","BK1574","06185","688185"],"gpt_icon":0},{"id":"2490847319","title":"康希诺生物(06185)下跌5.11%,报31.6元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490847319","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490847319?lang=zh_cn&edition=full","pubTime":"2024-12-12 10:31","pubTimestamp":1733970703,"startTime":"0","endTime":"0","summary":"12月12日,康希诺生物(06185)盘中下跌5.11%,截至10:31,报31.6元/股,成交2028.68万元。康希诺生物股份公司是一家专注于研发、生产和商业化优质人用疫苗的生物制品企业,致力于提供预防和治疗感染类疾病的解决方案,主要产品包括流脑结合疫苗、新冠病毒疫苗和埃博拉病毒疫苗等。公司在天津、上海建设了大规模现代化的疫苗产业基地,并在墨西哥、巴基斯坦、马来西亚等地建立生产线,其营销和供应体系覆盖中国、东南亚、中东以及拉美等地区。截至2024年三季报,康希诺生物营业总收入5.67亿元、净利润-2.22亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/12103146301028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06185","BK1574","BK1191","BK1161","BK1515"],"gpt_icon":0},{"id":"2490425478","title":"康希诺生物盘中异动 早盘急速下跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490425478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490425478?lang=zh_cn&edition=full","pubTime":"2024-12-12 10:31","pubTimestamp":1733970695,"startTime":"0","endTime":"0","summary":"2024年12月12日早盘10时31分,康希诺生物股票出现波动,股价急速跳水5.11%。截至发稿,该股报31.600港元/股,成交量63.16万股,换手率0.48%,振幅5.11%。机构评级方面,在所有9家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。康希诺生物股票所在的生物技术行业中,整体跌幅为0.30%。康希诺生物公司简介:许可项目:第三类医疗器械经营;药品生产;药品进出口;药品零售;药品批发;货物进出口;技术进出口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212103135ab71287a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212103135ab71287a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1191","688185","BK1515","BK1574","06185"],"gpt_icon":0},{"id":"2490841395","title":"南向资金12月11日净买入康希诺生物8.46万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2490841395","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490841395?lang=zh_cn&edition=full","pubTime":"2024-12-12 09:30","pubTimestamp":1733967026,"startTime":"0","endTime":"0","summary":"12月11日, 南向资金增持康希诺生物8.46万股,连续5日增持。截止当日收盘,港股通共持有康希诺生物4556.00万股,占流通股34.33%。康希诺生物近5个交易日上涨11.56%,港股通累计增持74.96万股;近20个交易日上涨5.21%,港股通累计增持289.12万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212093303ab710180&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212093303ab710180&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1161","BK1515","BK1574","06185","688185"],"gpt_icon":0},{"id":"2490016887","title":"智通AH统计|12月11日","url":"https://stock-news.laohu8.com/highlight/detail?id=2490016887","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490016887?lang=zh_cn&edition=full","pubTime":"2024-12-11 16:15","pubTimestamp":1733904905,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,截止12月11日收盘,东北电气、浙江世宝、弘业期货分列AH溢价率前三位,溢价率分别为800.00%、377.99%、353.69%;美的集团、药明康德、招商银行分列AH溢价率末三位,溢价率分别为18.61%、19.16%、19.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1223454.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01812","03145","02208","06196","01057","LU0143863198.USD","01053","02318","02727","03606","81211","82318","00588","03678","00300","01211","02218","00670","002594","06690","399300","02880","00323","01288","00553","BYDDY","00187","01349","688981","00042","00548","01055","02238","02009","159982","PNGAY","HYDD.SI","03143","00981","06185","06655","00038","03968","02359","01033","601318","02338","02899"],"gpt_icon":1},{"id":"2490703220","title":"康希诺生物(06185)上涨5.14%,报34.75元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490703220","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490703220?lang=zh_cn&edition=full","pubTime":"2024-12-11 09:48","pubTimestamp":1733881696,"startTime":"0","endTime":"0","summary":"12月11日,康希诺生物(06185)盘中上涨5.14%,截至09:48,报34.75元/股,成交607.82万元。康希诺生物股份公司是一家专注于研发、生产和商业化优质人用疫苗的生物制品企业,致力于提供预防和治疗感染类疾病的解决方案,主要产品包括流脑结合疫苗、新冠病毒疫苗和埃博拉病毒疫苗等。公司在天津、上海建设了大规模现代化的疫苗产业基地,并在墨西哥、巴基斯坦、马来西亚等地建立生产线,其营销和供应体系覆盖中国、东南亚、中东以及拉美等地区。截至2024年三季报,康希诺生物营业总收入5.67亿元、净利润-2.22亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/11094846242242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06185","BK1515","BK1161","BK1191","BK1574"],"gpt_icon":0},{"id":"2490036170","title":"康希诺生物盘中异动 急速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490036170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490036170?lang=zh_cn&edition=full","pubTime":"2024-12-11 09:48","pubTimestamp":1733881696,"startTime":"0","endTime":"0","summary":"2024年12月11日早盘09时48分,康希诺生物股票出现波动,股价大幅拉升5.14%。截至发稿,该股报34.750港元/股,成交量17.82万股,换手率0.13%,振幅5.14%。康希诺生物股票所在的生物技术行业中,整体跌幅为0.46%。其相关个股中,思路迪医药股份、药明巨诺-B、康希诺生物涨幅较大,振幅较大的相关个股有晶泰控股-P、思路迪医药股份、北海康成-B,振幅分别为10.39%、9.01%、5.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211094816a1e4c935&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211094816a1e4c935&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06185","BK1161","BK1191","BK1515","BK1574","688185"],"gpt_icon":0},{"id":"2490710519","title":"智通AH统计|12月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2490710519","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490710519?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:15","pubTimestamp":1733732105,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,截止12月9日收盘,东北电气、浙江世宝、安德利果汁分列AH溢价率前三位,溢价率分别为743.75%、366.87%、359.64%;美的集团、招商银行、药明康德分列AH溢价率末三位,溢价率分别为13.18%、17.60%、18.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1222102.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02338","02318","03678","399300","002594","01787","06690","PNGAY","159982","06066","03145","82318","06869","BYDDY","02359","00323","01138","00553","LU0197773673.USD","601318","01057","01349","02899","06099","00042","01033","06185","LU0737861699.HKD","02218","BK1149","01211","03606","02880","81211","00300","02727","03968","02009","09989","00187","01812","03143","HYDD.SI","00038","01772","00548","01456","688981"],"gpt_icon":1},{"id":"1146340250","title":"异动解读 | 康希诺生物(06185)盘中大涨5.02%,业务发展获市场看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1146340250","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146340250?lang=zh_cn&edition=full","pubTime":"2024-12-06 11:22","pubTimestamp":1733455363,"startTime":"0","endTime":"0","summary":"康希诺生物今日盘中大涨5.02%,引起了市场的广泛关注。作为一家中国疫苗研发生产商,康希诺生物拥有五个商业化疫苗产品和广阔的在研疫苗组合,旨在针对包括脑膜炎球菌疾病、新冠肺炎和埃博拉病毒等全球巨大且供不应求的疾病市场。财报数据显示,今年前三季度康希诺生物实现营收5.67亿元人民币,同比大增222.88%,主要得益于流脑疫苗产品销售收入的快速增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 康希诺生物(06185)盘中大涨5.02%,业务发展获市场看好","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06185"],"gpt_icon":0},{"id":"2489424837","title":"康希诺生物盘中异动 早盘急速上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489424837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489424837?lang=zh_cn&edition=full","pubTime":"2024-12-06 11:21","pubTimestamp":1733455277,"startTime":"0","endTime":"0","summary":"2024年12月06日早盘11时21分,康希诺生物股票出现波动,股价急速上涨5.17%。截至发稿,该股报33.550港元/股,成交量111.41万股,换手率0.84%,振幅5.33%。机构评级方面,在所有9家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。康希诺生物股票所在的生物技术行业中,整体涨幅为0.99%。其相关个股中,北海康成-B、巨子生物、云康集团涨幅较大,振幅较大的相关个股有北海康成-B、来凯医药-B、永泰生物-B,振幅分别为29.23%、13.75%、13.30%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206112117971c054c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206112117971c054c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06185","BK1515","BK1574","688185","BK1191","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cansinotech.com","stockEarnings":[{"period":"1week","weight":-0.0691},{"period":"1month","weight":0.0973},{"period":"3month","weight":0.5461},{"period":"6month","weight":0.5461},{"period":"1year","weight":0.342},{"period":"ytd","weight":0.3163}],"compareEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.1018},{"period":"1year","weight":0.2035},{"period":"ytd","weight":0.1653}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康希诺生物股份公司是一家处于临床阶段的中国疫苗公司。该公司的产品包括埃博拉病毒疫苗Ad5-EBOV、脑膜炎球菌疫苗MCV2和MCV4、肺炎球菌疫苗PBPV和重组新型冠状病毒疫苗等。其产品主要应用于脑膜炎、百白破和肺炎领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.023945},{"month":2,"riseRate":0.8,"avgChangeRate":0.176312},{"month":3,"riseRate":0.2,"avgChangeRate":-0.039813},{"month":4,"riseRate":0.666667,"avgChangeRate":0.073414},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.048095},{"month":6,"riseRate":0.5,"avgChangeRate":0.040455},{"month":7,"riseRate":0.5,"avgChangeRate":0.015509},{"month":8,"riseRate":0,"avgChangeRate":-0.182296},{"month":9,"riseRate":0.666667,"avgChangeRate":0.077531},{"month":10,"riseRate":0.5,"avgChangeRate":0.079945},{"month":11,"riseRate":0.666667,"avgChangeRate":0.127077},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.024759}],"exchange":"SEHK","name":"康希诺生物","nameEN":"CANSINOBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺生物(06185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺生物,06185,康希诺生物股票,康希诺生物股票老虎,康希诺生物股票老虎国际,康希诺生物行情,康希诺生物股票行情,康希诺生物股价,康希诺生物股市,康希诺生物股票价格,康希诺生物股票交易,康希诺生物股票购买,康希诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺生物(06185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}